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Abstract
Background: Following injury to the central nervous system, increased microglia, secretion of pro- and anti-inflammatory
cytokines, and altered blood-brain barrier permeability, a hallmark of degeneration, are observed at and immediately
adjacent to the injury site. However, few studies investigate how regions remote from the primary injury could also suffer
from inflammation and secondary degeneration.
Methods: Adult female Piebald-Viral-Glaxo (PVG) rats underwent partial transection of the right optic nerve, with normal,
age-matched, unoperated animals as controls. Perfusion-fixed brains and right optic nerves were harvested for
immunohistochemical assessment of inflammatory markers and blood-brain barrier integrity; fresh-frozen brains
were used for multiplex cytokine analysis.
Results: Immediately ventral to the optic nerve injury, immunointensity of both the pro-inflammatory biomarker
inducible nitric oxide synthase (iNOS) and the anti-inflammatory biomarker arginase-1 (Arg1) increased at 7 days
post-injury, with colocalization of iNOS and Arg1 immunoreactivity within individual cells. CD11b+ and CD45+ cells
were increased 7 days post-injury, with altered BBB permeability still evident at this time. In the lower and middle optic
tract and superior colliculus, IBA1+ resident microglia were first increased at 3 days; ED1+ and CD11b+ cells were first
increased in the middle and upper tract and superior colliculus 7 days post-injury. Increased fibrinogen immunoreactivity
indicative of altered BBB permeability was first observed in the contralateral upper tract at 3 days and middle tract at
7 days post-injury. Multiplex cytokine analysis of brain homogenates indicated significant increases in the pro-
inflammatory cytokines, IL-2 and TNFα, and anti-inflammatory cytokine IL-10 1 day post-injury, decreasing to
control levels at 3 days for TNFα and 7 days for IL-2. IL-10 was significantly elevated at 1 and 7 days post-injury
with a dip at 3 days post-injury.
Conclusions: Partial injury to the optic nerve induces a complex remote inflammatory response, characterized by
rapidly increased pro- and anti-inflammatory cytokines in brain homogenates, increased numbers of IBA1+ cells
throughout the visual pathways, and increased CD11b+ and ED1+ inflammatory cells, particularly towards the synaptic
terminals. BBB permeability can increase prior to inflammatory cell infiltration, dependent on the brain region.
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Background
Following an injury to a white matter tract in the central
nervous system (CNS), axons located at the primary in-
jury site are lesioned and degenerate [1]. Neurons and
glia spatially separated from the site of initial injury to
axons undergo further damage and activation due to
secondary degeneration [2]. Inflammation following
CNS trauma is responsible for both beneficial and detri-
mental effects, contributing to secondary damage but
also facilitating neurorepair [3]. Activation of resident
microglia, secretion of immune mediators such as pro-
and anti-inflammatory cytokines/chemokines, and infil-
tration of blood leukocytes characterize this robust in-
flammatory response [4]. The release of reactive oxygen
species (ROS) is a key pro-inflammatory feature, leading
to glial activation and oxidative damage in the tissue sur-
rounding the initial injury site [5] early after injury [6,
7]. Protective anti-inflammatory responses include mye-
lin debris phagocytosis [8, 9] and neurotrophic and
growth factor secretion [10]. Astrocyte activation leads
to a breach of the blood-brain barrier (BBB), with in-
creased monocyte extravasation [11] and associated in-
creases in Ca2+ and oxidative cascades of injury to both
axons and glia, further contributing to spreading of de-
generation [12].
Because macrophages and microglia are key modulator
and effector cells in the immune response, much attention
has been devoted to defining the dynamics of pro- and
anti-inflammatory effects of trauma-induced inflammation
within the linear constraints of microglia/macrophage
polarization phenotypes, namely anti-inflammatory “M1”
vs pro-inflammatory “M2” [5, 13–17]. The in vivo envir-
onment is complex and presents a variety of pro- and
anti-inflammatory stimuli simultaneously [18–20]. In fact,
recent in vivo studies of inflammation following CNS
trauma have highlighted the plasticity of these cells where
the same cell population is able to switch between
polarization states in response to mediators in their sur-
rounding microenvironment, and yet, others report the
concurrent expression of both pro- and anti-inflammatory
markers by a single cell [21–24]. These findings suggest a
lack of exclusivity in microglia/ macrophage activation
states in vivo and indicate that the same cell responsible
for promoting neuroinflammation can also release factors
that promote wound healing. It is likely that the combin-
ation and balance of multiple factors (i.e., glial cells, im-
mune cells, pro- and anti-inflammatory cytokines/
chemokine levels, time elapsed after injury, and lesion
magnitude) will lead to different degrees of damage, as has
been described in a range of injury models including glau-
comatous damage at the optic nerve head, partial optic
nerve transection, and spared nerve injury [25–27].
Furthermore, it is increasingly understood that specific
monocyte, macrophage, and other glial and endothelial
cell-derived cytokines play important roles in maintaining
or perturbing BBB permeability, thereby further modulat-
ing the injury response [28]. Characterizing the magni-
tude, timing, and duration of expression of these
mediators has the potential to offer mechanistic insight
and aid in the development of novel therapeutics.
Despite the plethora of research on trauma-induced
inflammation at the site of a primary injury and immedi-
ately adjacent, relatively few studies investigate how re-
gions remote from the primary injury site could also
suffer from secondary degeneration and inflammation
following neurotrauma [29–31]. Clinical studies suggest
a link between remote damage and symptomatology, a
phenomenon termed “diaschisis,” which contributes to
functional impairments [32–34]. Previous studies in the
spinal cord have shown that remote injury induces sub-
stantial changes in microglia and astrocytes, which con-
tribute to central inflammatory responses [35, 36]. In
addition, peripheral nerve injury evokes trafficking of
immune cells from the circulation into the spinal cord
parenchyma [37]. Using our in vivo partial optic nerve
transection model of secondary degeneration in adult
Piebald-Viral-Glaxo (PVG) female hooded rats, we have
previously demonstrated that a remote injury in the
CNS (optic nerve) can cause a transient opening of the
BBB in the visual pathways of the brain as early as 1 day
following injury, with Evans blue fluorescence visible
around the optic chiasm, optic tract, lateral geniculate
nucleus, and superior colliculus. BBB permeability was
maximal at 3 days following injury and decreased to
levels not significantly different from uninjured controls
at 7 days [38]. An initial analysis of the inflammatory re-
sponse early (1 day) following injury indicated that ED1
+ and IBA1+ microglia/macrophage activation occurred
along the length of the injured optic nerve, in the optic
chiasm, and adjacent to the cerebral ventricles [38], and
earlier studies have shown increases in these cells imme-
diately adjacent to the injury at 3 days [25]. However, a
quantitative assessment of a range of inflammatory cell
subtypes along the optic tract and into the superior col-
liculus is lacking. Furthermore, the spatiotemporal rela-
tionship between inflammation and blood-brain barrier
breach remote to an injury is unknown. Specifically, it is
not yet clear whether inflammatory cells that rapidly in-
filtrated the injury site spread along the optic nerve and
tract into the brain, thereby initiating BBB breakdown.
Alternative hypotheses include axonal degeneration and
compromise of axonal transport initiating remote in-
flammation and BBB breakdown close to synaptic termi-
nals in the superior colliculus or systemic changes
contributing to a widespread inflammatory response.
Here, we assess microglia and macrophage dynamics
together with indicators of BBB breach and cytokine
profiles, at various sites distal to a partial optic nerve
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transection injury, focusing on identifying the time at
which changes are first observed in order to determine
in a region-specific manner, whether blood-brain barrier
breach precedes inflammation.
Methods
Animal procedures
Adult female PVG hooded rats (160–180 g) were bred at
the Animal Resources Centre (Murdoch, WA, Australia),
housed under a standard 12-h light/dark cycle and fed
standard rat chow and water ad libitum. Procedures ad-
hered to the National Health and Medical Research
Council Australian Code of Practice for the care and use
of animals for scientific purposes and were approved by
the University of Western Australia’s Animal Ethics Com-
mittee, approval numbers RA3/100/1201, RA3/100/673,
and RA3/100/1485. The rats were anesthetized intraperi-
toneally with a combination of xylazine (Ilium Xylazil,
Troy Laboratories, 10 mg/kg) and ketamine (Ketamil,
Troy Laboratories, 50 mg/kg), and euthanized with an in-
traperitoneal injection of Euthal (pentobarbitone sodium
850 mg/kg; phenytoin sodium 125 mg/kg; Virbac).
The partial optic nerve transection procedure was
similar to that described previously [25]. Briefly, anesthe-
tized rats were shaved along the skull towards the right
eye. Under aseptic conditions, the skin was incised and
retracted, and the right optic nerve accessed by deflect-
ing the Harderian lachrymal gland immediately behind
the right eye. The nerve parenchyma was exposed about
1 mm behind the eye by making a slit in the dura mater
with ophthalmic scissors. A controlled 200-μm cut was
made in the dorsum of the right optic nerve using a dia-
mond radial keratotomy knife (Geuder), with the depth
determined by the protrusion of the blade beyond a sur-
rounding guard. Care was taken not to stretch the optic
nerve or damage major ophthalmic blood vessels. The
deflected tissue was replaced, and the skin was sutured
with 4/0 non-absorbable silk suture. The eyes were lu-
bricated with Luxyal eye drops, and the rats were placed
on a warming blanket for recovery with subcutaneous
injections of analgesic (Carprieve, 5 mg kg−1 in sterile
water, Norbrook Australia, Pty. Ltd.; Victoria, Australia)
and sterile PBS (1 ml). No postoperative infections were
observed.
The right optic nerves from normal, age-matched,
unoperated animals were used as controls, as
sham-operated animals have been shown to be not dif-
ferent to normal in terms of a range of relevant cellular
and oxidative stress outcomes [25]. Three cohorts of ani-
mals were used, with animals within each cohort being
randomized into groups reflecting the number of days
post-injury, for details see Table 1. In brief, cohort 1 was
used for immunohistochemical studies assessing micro-
glia/macrophages in the right optic nerves of animals at
3, 7, and 28 days post-injury and in uninjured controls.
For cohort 1, three groups of uninjured controls col-
lected at days 3, 7, and 28 were compared and found to
be not different (ANOVA, p > 0.05); the 3-day controls
were used for statistical comparisons. Cohort 2 was used
for BBB analyses in the optic tracts and superior collicu-
lus of animals at 3, 7, 14, and 28 days post-injury and in
uninjured controls, assessing the presence of Evans blue
dye. Once it was established that no Evans blue dye was
visible in the optic tracts and superior colliculus, a sub-
set of cohort 2 was randomly selected for immunohisto-
chemical studies assessing microglia and macrophages as
well as fibrinogen and caveolin-1 immunoreactivity with
increases being surrogate markers for BBB breach in
these brain regions (n = 5–6/group). Cohort 3 was used for
cytokine analyses in the homogenized brains of animals at
1, 3, and 7 days post-injury and in uninjured controls.
Immunohistochemistry, microscopy and analysis
Animals for BBB analyses (cohort 2) were administered
a 2% (w/v) sterile solution of Evans blue (Sigma,
E2129_10G) in PBS (2.8 ml/kg) via tail vein injection 1 h
prior to euthanasia. Immediately following euthanasia,
the animals for cohorts 1 and 2 (BBB and immunohisto-
chemical assessments) were transcardially perfused-fixed
with 0.9% (w/v) saline followed by 4% (w/v)
Table 1 Summary of cohorts and numbers of animals per group
Uninjured Day 1 Day 3 Day 7 Day 14 Day 28
Cohort 1
- Microglia/macrophages in the optic nerve n = 10* n = 10 n = 10 n = 10
Cohort 2
- BBB analyses n = 9–12 EB n = 9–12 EB n = 9–12 EB n = 9–12 EB n = 9–12 EB
- Microglia/macrophages in the optic tract n = 9 n = 6 no EB n = 6 n = 5–6 n = 4–5 n = 4
Cohort 3
- Cytokines n = 8 n = 8 n = 8 n = 8
Day is the day after partial optic nerve transection injury. * For cohort 1, three groups of uninjured controls collected at days 3, 7, and 28 were compared and found to
be not different (p ≤ 0.05); the 3-day controls were used for statistical comparisons. EB denotes intravenous injection of Evans blue for the specified animals. Numbers of
animals per group are presented as a range if suitable sections were not available for specific brain regions. BBB analyses encompass assessments of Evans blue, caveolin,
and fibrinogen immunoreactivity
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paraformaldehyde (Sigma-Aldrich; St. Louis, Missouri,
USA) in 0.1 M phosphate buffer, pH 7.2–7.4. The right
optic nerves and brains were harvested and post-fixed in
4% paraformaldehyde for 1 h (nerves) or overnight
(brains) and then cryoprotected in 15% sucrose in PBS
and stored at 4 °C. The optic nerves were cryosectioned
transversely (14 μm thickness), and the brains were
cryosectioned coronally (20 μm thickness) and collected
onto a series of slides so that each slide had a represen-
tative section from each area of interest. Sections for Ev-
ans blue analysis were collected onto Superfrost® Plus
slides, air dried for an hour, and only briefly rinsed in
PBS to reduce leakage of the dye from the sections be-
fore mounting using Fluoromount-G (Southern Biotech).
The sections for immunohistochemistry were collected
onto Superfrost® Plus slides and stored at − 80 °C.
Immunohistochemical analyses were conducted accord-
ing to the previously described procedures [39]. Primary
antibodies used for immunohistochemical assessments of
the optic nerves detected inducible nitric oxide synthase
(iNOS) (1:400, BD Biosciences, ab3523), Arginase-1
(Arg-1) (1:400, Santa Cruz Biotechnology, sc-18355),
CD45 (1:200, BD Pharmingen, 555482), and CD11b
(1:400, 553310, BD Pharmingen). Primary antibodies used
for immunohistochemical assessments of the brains (optic
tracts and superior colliculus) recognized CD45 (1:500,
Abcam, ab10558), CD11b (1:300, Sapphire Bioscience,
ab2910), ionized calcium-binding adapter molecule 1
(IBA1) (1:1000, Abcam, ab5076), CD68 (ED1) (1:1000,
Millipore Corporation, MAB1435), Caveolin-1 (1:400,
Sapphire Bioscience, Ab2910), and Fibrinogen (1:500,
HiTech Group Australia, A008002). Secondary antibodies
were species-specific AlexaFluor 488-, 555-, and
647-conjugated antibodies (1:500, Invitrogen Australia).
All tissue sections for a particular immunohistochemical
outcome were processed at the same time.
Fluorescence imaging was performed using a Nikon
Si1 inverted microscope (Nikon Corporation, Japan) for
the right optic nerve and optic tract assessments of
microglia and macrophages and a Leitz Diaplan micro-
scope with an Olympus DP70 camera controlled by DP
controller (version 2.1.1.183) for superior colliculus; a
confocal Nikon C2 mounted on an upright Ni-E micro-
scope, for assessments of BBB integrity (Evans blue
fluorescence, fibrinogen, and caveolin-1 immunoreactiv-
ity), or for immunohistochemical assessments of micro-
glia and macrophages in the brain (optic tracts and
superior colliculus). Images from the Nikon microscopes
were captured in a stack of 13 optical slices at 0.5 μm in-
crements along the z-axis, obtained from the middle
6 μm of the section, controlled by NIS elements 4.3
software. All images for assessment of each outcome
measure were captured at a constant exposure, using
consistent microscope settings.
A single section was selected for optic nerves that
showed the dorsal injury site and the ventral nerve. The
fields of view imaged were located in the ventral portion
of the right optic nerve of that section, directly below the
dorsal primary injury site. The intensities of iNOS and
Arg-1 immunoreactivity were assessed on the single cen-
tral optical slice most in focus from the relevant 13 image
z-stack. Mean fluorescence intensities were quantified on
the whole image of ventral optic nerve and were normal-
ized by subtracting the average of three randomly selected
background regions of interest per animal. The numbers
of CD45+ and CD11b+ cells were assessed within similar
regions of interest. This non-stereological technique does
not allow for an estimate of total cell numbers within the
nerve but does allow for comparative assessment between
time points after injury. Similarly for the brains, assess-
ments of the numbers of CD45+, CD11b+, IBA1+, and
ED1+ cells were conducted in single visual slices from im-
ages of single sections capturing either the lower, middle,
or upper regions of both the ipsilateral and contralateral
optic tracts and at the rostral end of the superior collicu-
lus for each animal (Fig. 1). While sampling of more than
one section may have been preferable, the brain regions of
interest were often only clearly present in one section per
slide. The optic tract is relatively small and was only ap-
parent in one section per region of interest per slide along
the rostrocaudal plane. Similarly, the optic nerve injury
site, and therefore the ventral region directly under the in-
jury, is only clearly apparent in one or two sections per
slide. Not all markers were assessed for all regions at all
time points; analyses were based on identifying the first
time at which significant increases were observed and at
times were constrained by the availability of sections con-
taining the precise region of interest (e.g., superior collicu-
lus at day 1). The numbers of positively stained cells
within each field of view were expressed per unit area. As-
sessments of Evans blue fluorescence were conducted
qualitatively, scanning multiple sections of the right optic
nerves and regions throughout the brain including optic
tracts, ventricles, choroid plexus, and the superior collicu-
lus and applying a score to fluorescence; representative
images are shown. Caveolin-1 immunoreactivity of endo-
thelial cells lining the ventricles in the brain was quanti-
fied by measuring the length of immunoreactive cells
expressed as a percentage of the total length of the lining
of the ventricle that was visible in the single image used
for analysis; the choice of section for imaging was based
upon ventricle size and shape to ensure consistency of the
region of analysis for all animals. Assessment of fibrinogen
immunofluorescence was performed throughout the optic
tracts, on single central visual slices from the relevant 13
image z-stack. Fibrinogen was quantified as mean fluores-
cent intensity and the area above the threshold as a per-
centage of the total area of interest. Threshold values were
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normalized to the background of each image by dividing
the average of three random background measurements
by the average background of a control image then multi-
plying the original threshold value by this transformation
factor. Average intensities above the threshold were nor-
malized by subtracting the background from the mean
fluorescence intensity.
Cytokine measurements—multiplex assay
Rats from cohort 3 (n = 8 per group) were euthanized
and transcardially perfused with ice-cold 0.9% saline,
after which the brains were harvested, washed with
ice-cold PBS, and homogenized in ice-cold RIPA buffer
(Sigma Aldrich) supplemented with 1× protease inhibi-
tor cocktail (Sigma Aldrich) (10 ml). Brain homoge-
nates were incubated on ice for 20 min to aid protein
solubilization, after which they were centrifuged at
12000g for 20 min at 4 °C, and the lysates were stored
at − 80 °C until use. Total protein concentration of the
brain lysates from each animal was determined using
the Pierce BCA Protein Assay Kit (Thermo Fisher
Scientific Pty Ltd.) according to the manufacturer’s
instructions.
The concentration of ten cytokines (GM-CSF,
Interleukin (IL)-12, Interferon (IFN)-γ, IL-1α, IL-1β,
IL-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)-α)
in brain lysates was determined using the Cytokine Rat
Magnetic 10-Plex Panel kit (Life Technologies)
according to the manufacturer’s instructions using the
Luminex® 200™ system (CMCA). Briefly, brain lysates
were thawed, clarified by centrifugation (1000g for
10 min at 4 °C), and standardized at 500 μg/ml protein
using assay diluent provided in the Rat Cytokine
10-Plex kit. Lyophilized cytokine standards (Rat
Cytokine 10-Plex kit) were reconstituted in assay dilu-
ent (Rat Cytokine 10-Plex kit), and 1:3 serial dilutions
were performed with assay diluent as instructed (Rat
Cytokine 10-Plex kit) to give seven standard solutions.
Colored magnetic beads conjugated with cytokine anti-
bodies (Rat Cytokine 10-Plex kit) were reconstituted in
1× wash solution (Rat Cytokine 10-Plex kit) to give a
1× antibody bead solution, which was then pipetted
into 80 wells of a 96-well plate (25 μl/well). The anti-
body beads were washed twice with 1× wash solution
(200 μl/well). Following washing, prepared incubation
buffer (Rat Cytokine 10-Plex kit) was added to each of
the 80 wells (50 μl/well). Seven cytokine standard solu-
tions were added in duplicate to wells designated for
standards (100 ul/well), assay diluent was added in du-
plicate to wells designated for blanks (100 μl/well), and
the 32 brain lysate samples from each animal (500 μg/ml)
were added in duplicate to wells designated for samples
(50 μl of sample + 50 μl of assay diluent), following which
the plate was incubated at room temperature on a shaking
platform (2 h) to enable cytokines to bind to their respect-
ive antibody beads. Following incubation, the wells were
washed twice with 1× wash solution (200 μl/well), and
Fig. 1 Schematic overview of the regions of interest used for quantification of the inflammatory response following partial injury to the optic nerve.
The ventral aspect of the optic nerve (gray box) was used to quantify Arg1 and iNOS immunoreactivity and CD11b and CD45 cell density. The lower (blue
box), middle (yellow box), and upper (red box) tracts were used to quantify the density of CD11b-, IBA1-, ED1-, CD45-, and CD11b/IBA1/ED1-positive cells
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subsequently, a 1× biotinylated antibody solution (Rat
Cytokine 10-Plex kit) containing a mixture of biotinylated
antibodies against each cytokine was added to each of the
80 wells (100 μl/well) and incubated at room
temperature on a shaking platform (1 h). Following
incubation, the wells were washed twice with 1× wash
solution (200 μl/well), and subsequently, a 1×
streptavidin-phycoerythrin solution (Rat Cytokine
10-Plex kit) was added to each of the 80 wells
(100 μl/well) and incubated at room temperature on a
shaking platform (30 min). Following incubation, the wells
were washed thrice with 1× wash solution (200 μl/well)
and stored in 1× wash solution (125 μl/well) overnight at
4 °C. The following day, working wash solution was dec-
anted, and fresh 1× working wash solution was added
(125 μl/well). The plate was then placed on a shaking plat-
form (3 min) and inserted into an XY platform on the
Luminex® 200™ system (CMCA) to measure cytokine con-
centrations for each sample calculated against the stand-
ard curve. Each well was sampled using a volume of 75 μl
and a bead count of 100 per analyte before advancing to
the next well.
Data analysis and statistics
Data are presented as mean ± standard error of mean. Statis-
tical analyses of activated microglia and macrophage dens-
ities, Arg1 and iNOS immunointensities, and caveolin-1 and
fibrinogen immunoreactivity were performed on SPSS
(IBM) software, using one-way ANOVA or two-way ANO-
VAs to compare regions at a particular time point. For
two-way ANOVAs, overall p, F, and df values are provided,
with p, F, and df values provided for subsets where signifi-
cance was reached. Tukey post hoc tests were used for optic
nerve data and Sidak post hoc tests for optic tract data. If
Levene’s test indicated inequality of variances, data were log
or square root transformed for two-way ANOVAs or
Games-Howell post hoc tests employed for one-way ANO-
VAs. Post hoc p values were provided where significance
was reached using ANOVAs. Statistical analyses of cytokine
data were performed on GraphPad Prism 6 software using
Fig. 2 Semi-quantification of iNOS and Arg1 immunoreactivity in ventral ON vulnerable to secondary degeneration. Mean ± SEM fluorescence
intensity of a iNOS and c Arg1 in the control optic nerve and at 3, 7, and 28 days following partial optic nerve transection, in ventral optic nerve
vulnerable to secondary degeneration are shown. * indicates significantly different from normal (p≤ 0.05), n = 10/group. Representative low- and high-
magnification images of b iNOS and d Arg1 in the ventral aspect of the optic nerve are shown in control uninjured, 3, 7, and 28 days after injury.
Examples of iNOS- and Arg1-positive cells are indicated by “>.” Scale bar of b and d: 40 μm top images and 10 μm bottom images for each
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Fig. 3 Representative images of iNOS and Arg-1 colocalization in ventral ON vulnerable to secondary degeneration. iNOS+/Arg1+cells are yellow and
indicated by white arrows, particularly apparent 7 and 28 days after injury to the optic nerve, n = 6/group. Scale bar: 10 μm
Fig. 4 Quantification of CD11B+ and CD45+ cells in ventral ON vulnerable to secondary degeneration. Mean ± SEM numbers of a CD45+ and c
CD11b+ cells in control, uninjured optic nerve and at 3, 7, and 28 days following partial optic nerve transection, in ventral optic nerve vulnerable
to secondary degeneration are shown. * indicates significantly different from normal (p≤ 0.05), n= 6/group. Representative low- and high-magnification
images of b CD45 and d CD11b in the ventral aspect of the optic nerve are shown in control uninjured, 3, 7, and 28 days after injury. Examples of CD45+
and CD11b+ cells, boxed cells at low magnification, are shown in high magnification. Scale bar of b and d: 20 μm top images and 3 μm bottom images
for each
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one-way ANOVA to compare means of n = 8 animals at
each time point, conducted individually for each cytokine,
using Tukey post hoc tests.
Results
Inflammatory responses in optic nerve immediately adjacent
to the primary injury
Semi-quantitative assessment 3, 7, and 28 days after in-
jury in the ventral portion of the right optic nerve dir-
ectly below the dorsal primary injury site revealed
significant increases in the immunointensity of both the
pro-inflammatory biomarker inducible nitric oxide syn-
thase (iNOS) (Fig. 2a, b) and anti-inflammatory bio-
marker arginase-1 (Arg-1) (Fig. 2c, d) at 7 days (p ≤ 0.05,
F = 5.04, df = 38 and p ≤ 0.05, F = 7.41, df = 38, respect-
ively). Immunointensity of iNOS returned to control
levels 28 days after injury (p > 0.05), while arg-1
remained elevated (p ≤ 0.05). Contrary to the microglia/
macrophage “polarization” phenotype previously de-
scribed [40], we demonstrate colocalization of iNOS and
Arg1 immunoreactivity within individual cells, evident 7
and 28 days after injury (Fig. 3).
The numbers of cells expressing CD11b (complement 3
receptor) a constitutive marker of leukocytes and CD45
which is expressed on all nucleated hematopoietic cells
was assessed in the ventral portion of the right optic
nerve. Quantification of CD45+ and CD11b+ microglia
and macrophages demonstrated significant increases in
the numbers of both CD45+ and CD11b+ cells 7 days
after injury (p ≤ 0.05, F = 4.74, df = 23 and p ≤ 0.05, F = 9.15,
df = 23, respectively) (Fig. 4a, c). The numbers of
CD11b+ cells remained significantly higher than in unin-
jured controls at 28 days post-injury (p ≤ 0.05) (Fig. 4c, d),
whereas CD45+ cells returned to levels not different from
control at this time point (p > 0.05) (Fig. 4a, b).
Inflammatory cell responses in the brain
Changes in densities of inflammatory cell populations
were assessed in the lower, middle, and upper optic
tracts (i.e., progressing from juxta-chiasmal = lower;
Fig. 5 Quantification of CD11b+ cells in the optic tract of the brain. Mean ± SEM numbers of a CD11b+ cells in the lower, middle, and upper
regions of the optic tract in control uninjured optic nerve, compared to 1, 3, 7, 14, and 28 days following partial optic nerve transection, assessed
separately for the right and left hand sides of the brain, n = 5–6/group. *p ≤ 0.05, **p≤ 0.01, ***p≤ 0.001, ****p≤ 0.0001. Representative images of
infiltrating CD11b+ cells in the b lower, c middle, and d upper optic tract, in control uninjured, and 7–14 days following partial optic nerve transection:
D is day. Scale bar of b–d: 100 μm
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mid-way between the chiasm and the superior colliculus
= middle; pre-superior colliculus = upper) of the brain
at 1, 3, 7, 14, and 28 days following partial injury to the
optic nerve. Time points were chosen to complement
the optic nerve analyses of the present study together
with published work assessing microglia and macro-
phages in the partial optic nerve cut model [25, 39].
CD11b+ cells were assessed on both the left and right
optic tracts, corresponding to the contralateral and ipsi-
lateral sides to the injury, respectively. Two-way
ANOVA revealed no significant changes in the densities
of CD11b+ leukocytes in the lower tracts, compared to
uninjured controls (p = 0.17, F = 1.63, df = 5) (Fig. 5a).
There were changes in the number of CD11b+ cells/mm2
in the middle (two-way ANOVA: p = 2 × 10−3, F = 4.53,
df = 5; contralateral: p = 0.02, F = 3.09, df = 5; ipsilateral:
p = 0.17, F = 1.69, df = 5) and upper tracts (two-way
ANOVA: p = 1 × 10−4, F = 6.217, df = 5; contra-
lateral: p = 9 × 10−3, F = 3.95, df = 5; ipsilateral:
p = 0.051, F = 2.561, df = 5), with post hoc analysis reveal-
ing a significant increase relative to uninjured controls
7 days post-injury on the contralateral side (p = 0.03, mid-
dle tract; p = 0.01, upper tract), returning to control levels
at day 14 (Fig. 5b, c).
Additional analyses were conducted focusing on the
contralateral optic tract, to investigate first increases in
further microglial/ macrophage subpopulations in a sub-
set of sections of the optic tract at 1, 3, and 7 days fol-
lowing partial injury to the optic nerve. CD11b+ cells
that also colocalized with IBA1 (a microglia/ macro-
phage marker which recognizes both resident and acti-
vated microglia/ macrophages) and ED1 (a marker of
resident and infiltrating activated macrophages) were
unchanged in the lower tract at the measured time
points (p = 0.14, F = 2.29, df = 2) but significantly
increased at 7 days compared to uninjured controls in the
middle (p = 6 × 10−4, F = 13.54, df = 2) and upper tract
(p = 0.03, F = 20.33, df = 2) (Fig. 6a, b), indicating that
Fig. 6 Quantification of CD11b+/IBA1+/ED1+ cells in the optic tract of the brain. Mean ± SEM numbers of a CD11b+/IBA1+/ED1+ cells across the
lower, middle, and upper regions of the optic tract in control uninjured optic nerve, compared to 3 and 7 days following partial optic nerve
transection. n = 6 for control, n = 5 for 3 and for 7 days. *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001, ****p≤ 0.0001. Representative images of b CD11b
+/IBA1+/ED1+ cells, indicated by “>,” in the lower region of the optic tract in control uninjured, 3 and 7 days following partial optic nerve
transection. Scale bar of b: 5 μm
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activation was enhanced in these regions. In contrast to
outcomes within the optic nerve, there were no changes in
the density of CD45+-positive cells in the contralateral optic
tract. Quantification of CD45+ microglia and macrophages
did not reveal any significant changes at 3 or 7 days
following injury in any of the optic tract regions analyzed
(p = 0.57, F = 0.59, df = 2 for lower; p = 0.41, F = 0.96,
df = 2 for middle; and p=0.60, F=0.53, df = 2 for upper
optic tract) (Fig. 7a, b).
Cells positive for the markers IBA1 and ED1 in isolation
were also quantified in the contralateral optic tract at 3 and
7 days post-injury. Density of IBA1+ cells significantly in-
creased from uninjured controls at 3 days post-injury, with
a further increase at 7 days post-injury in the lower (p= 1 ×
10−4, F = 20.08, df = 2; 3 days p = 0.01, 7 days p = 0.01) and
middle (p= 7 × 10−6, F= 33.48, df = 2; 3 days p = 3 × 10−3,
7 days p = 4 × 10−3) regions of the optic tract. Increases in
the upper tract only reached significance at 7 days (p= 3 ×
10−5, F= 28.38, df = 2; 7 days p = 2 × 10−5) (Fig. 8a, b, e; high
and low magnification representative images, respectively).
The densities of ED1+ cells increased at 7 days following
injury in the lower, middle, and upper tracts (p = 7 × 10−5,
F = 23.33, df = 2; p = 0.00, F = 77.39, df = 2 ;and
p = 0.00, F = 87.61, df = 2, respectively; 7 days p=6×10−3,
p=1×10−4, p=0.00, respectively) (Fig. 8c, d, e; high and
low magnification representative images, respectively).
IBA1+ and ED1+ cells were also quantified in the su-
perior colliculus at 1, 3, and 7 days post-injury, assessing
both the contralateral and ipsilateral sides. IBA1+ cells
did not significantly change relative to control uninjured
nerve on either the contralateral or ipsilateral sides (p=0.057,
F=4.21, df =3; ipsilateral: p=0.25, F=1.46, df = 3) (Fig. 9a).
However, post hoc tests revealed that ED1+ cells were
significantly increased at day 7 on the contralateral side
(p = 0.002) (contralateral: p = 2 × 10−4, F = 10.47, df = 3;
ipsilateral: p = 0.50, F = 0.80, df = 3) (Fig. 9b).
Blood-brain barrier integrity
Extravasation of Evans blue dye into the brains of rats fol-
lowing partial optic nerve injury was assessed qualitatively,
Fig. 7 Quantification of CD45+ cells in the optic tract of the brain. Mean ± SEM numbers of CD45+ cells a across the lower, middle, and upper
regions of the optic tract in control uninjured optic nerve, compared to 3 and 7 days following partial optic nerve transection. n = 6 for control,
n = 5 for 3/7 days. Representative images of CD45+ cells (b), indicated by “>” in the lower region of the optic tract in control uninjured optic
nerve, and 3 and 7 days following partial ON transection. Scale bar for b: 3 μm
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being mindful of the caveats of this technique for asses-
sing BBB integrity [41]. Despite our earlier observations of
Evans blue dye in the brain at days 1 and 3 following this
injury using multispectral imaging and quantitative assess-
ment of extravasated Evans blue respectively [38], we did
not observe Evans blue fluorescence at above background
levels in cryosections of the brain viewed by confocal mi-
croscopy in the current study (Fig. 10a). The lack of Evans
blue fluorescence in the brain sections in the current
study may have been due to storage in sucrose and PBS
prior to sectioning, and the single washing of the brain
sections required to remove the OCT prior to section
mounting. Previously, we observed Evans blue dye in the
optic nerve at days 1 and 3 following injury [38]. In the
current study, assessment of later time points indicated
the presence of intense Evans blue staining at the optic
nerve injury site and low-intensity diffuse staining ventral
to the site of injury at 7 days post-injury (Fig. 10b).
However, Evans blue fluorescence was not different to
control at 28 days after partial transection (Fig. 10c, d), in-
dicating closure of the BBB in the optic nerve at this time
point after injury.
Caveolin-1 is a structural component of caveolae, me-
diates transcytosis through endothelial cells via interac-
tions with claudin [42], and can be used as an indicator
of BBB integrity [38]. Caveolin-1 immunoreactivity sur-
rounding the third ventricle was assessed at 3, 7, 14, and
28 days following injury, to provide insight regarding the
time of closure of the BBB following remote injury. The
percentage of the third ventricle lined with caveolin-1+
cells was not different to control at 3, 7, and 28 days
following partial optic nerve transection but was
significantly reduced at 14 days (ANOVA: p = 5 × 10−4,
F = 6.52, df = 4; 14 days p = 5 × 10−3) (Fig. 10e, f ), indicat-
ing a transient compromise of caveolin-1-mediated junc-
tions at this later time point.
Given the potential for washout of Evans blue dye
from the tissue sections, immunoreactivity of fibrinogen
was used as an additional measure of BBB integrity.
Fibrinogen is a blood-derived protein whose accumula-
tion in the brain indicates loss of BBB integrity [43]. The
area of fibrinogen immunoreactivity, indicative of the
size of the breach of the BBB, did not change with injury
in the optic chiasm (two-way ANOVA: p = 0.24, F = 1.41,
Fig. 8 Quantification of IBA1+ and ED1+ cells in the optic tract of the brain. Mean ± SEM numbers of a IBA1+ and c ED1+ cells across the
lower, middle, and upper regions of the optic tract in control uninjured optic nerve, compared to 3 and 7 days following partial optic nerve
transection. n = 6 for control, n = 5 for 3 and for 7 days. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001. Representative images of b IBA1+
and d ED1+ cells at high magnification, indicated by “>,” in the lower region of the optic tract in control uninjured optic nerve, and 3 and
7 days following partial optic nerve transection. Scale bar for b–d: 5 μm. e Representative images of IBA1+ and ED1+ cells at low
magnification, in the lower middle and upper regions of the optic tract in control uninjured optic nerve, and 7 days following partial optic
nerve transection. Scale bar: 100 μm
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df = 4) (Fig. 11a). However, the intensity of staining in
the chiasm, perhaps indicating a focal breach, did change
with injury (contralateral: p = 0.03, F = 3.10, df = 4; ipsi-
lateral: p = 2 × 10−3, F = 5.18, df = 4), with post hoc ana-
lysis revealing that increases in signal intensity relative
to control were confined to the ipsilateral side at 7 days
post-injury (p = 0.03) (Fig. 11b). Changes in the area of
fibrinogen immunoreactivity in the lower tract were seen
on both sides (contralateral: p = 0.02, F = 3.33, df = 4;
ipsilateral: p = 0.03, F = 2.98, df = 4); however, post hoc
tests only revealed differences between 7 and 28 days,
rather than relative to control (contralateral: p = 0.03;
ipsilateral: p = 0.04) (Fig. 11a). No differences in the in-
tensity of fibrinogen immunoreactivity were observed in
the lower tract (contralateral: p = 0.10, F = 2.09, df = 4;
ipsilateral: p= 0.27, F= 1.35, df = 4). In the middle tract,
changes in the area of fibrinogen immunoreactivity were
confined to the contralateral side (contralateral: p= 3× 10−4,
F= 7.12, df = 4; ipsilateral: p = 0.06, F = 2.48, df = 4),
with post hoc analysis revealing differences relative to
control 7 days post-injury (p = 4 × 10−3). There were
no significant differences in the intensity of fibrinogen im-
munoreactivity in the middle tract (contralateral: p = 0.24,
F = 1.45, df = 4; ipsilateral: p = 0.06, F = 2.55, df = 4).
Changes in the upper tract were similar to the middle
tract but occurred earlier (contralateral: p = 0.001,
F = 5.98, df = 4; ipsilateral: p = 0.69, F = 0.56, df = 4) with
post hoc tests showing that area of the breach increased at
day 3 on the contralateral side (p = 0.004) (Fig. 11a, c). No
changes were observed in the intensity of fibrinogen
immunoreactivity in the upper tract (contralateral:
p = 0.086, F = 2.26, df = 4; ipsilateral: p = 0.10, F = 2.10, df
= 4) (Fig. 11b). Finally, in the superior colliculus, no sig-
nificant changes in fibrinogen immunoreactivity were ob-
served for area (contralateral: p = 0.058, F = 2.95, df = 3;
ipsilateral: p = 0.06, F = 2.82, df = 3) or intensity of immu-
noreactivity (contralateral: p = 0.32, F = 1.23, df = 3; ipsilat-
eral: p = 0.16, F = 1.88, df = 3) (Fig. 11a, b).
Cytokine expression is altered in rat brains in a time-dependent
manner following partial injury to the optic nerve
The inflammatory response in the whole brain homoge-
nates following partial injury to the optic nerve was de-
termined by measuring changes in cytokine protein
levels in homogenized rat brains at 1, 3, and 7 days
post-injury compared to uninjured controls (Fig. 12).
While it would perhaps have been preferable to assess
the cytokines in the individual optic tract regions of
interest, the volume of tissue required for these assays
precluded these assessments. In these experiments, ten
cytokines were measured: IL-6, IL-1β, TNFα, IL-2, IL-4,
IL-10, IL-12, GMCSF, IL-1α, INFγ; however, differences
between injured and control rat brains were only de-
tected for three of them, TNFα, IL-2, and IL-10. The
pro-inflammatory cytokine, IL-1β, and the anti-inflam-
matory cytokine, IL-4, remained unaltered in injured rat
brains compared to controls, and five cytokines were
below the detection limit of the multiplex assay, IL-6,
IL-12, GMCSF, IL-1α, and INFγ. Tumor necrosis factor
(TNFα) is a multifunctional cytokine most often referred
to as a potent pro-inflammatory cytokine, produced by
microglia and astrocytes. There was a significant in-
crease in TNFα protein levels in rat brains in the early
time point, 1 day post-injury (1.6-fold increase ± 0.14)
compared to uninjured controls (p < 0.0001, F= 4.13, df = 3)
(Fig. 12). At 3 days post-injury, the concentration of TNFα
Fig. 9 Quantification of IBA1+ and ED1+ cells in the superior
colliculus. Mean ± SEM numbers of a IBA1+ and b ED1+ cells across
the lower, middle, and upper regions of the optic tract in control
uninjured optic nerve, compared to 3 and 7 days following partial optic
nerve transection. n= 6 for control, n= 5 for 3 and for 7 days. *p≤ 0.05,
**p≤ 0.01, ***p≤ 0.001, ****p≤ 0.0001
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Fig. 10 Evans blue fluorescence and caveolin immunoreactivity in the brain following partial optic nerve transection. Lack of Evans blue fluorescence in a
representative image of the periventricular region of the brain at 3 days after partial optic nerve transection (a), compared to strongly positive fluorescence
at the partial optic nerve injury site 7 days after injury (b). Evans blue fluorescence in optic nerve 28 days after injury (c) was not different from uninjured
controls injected with Evans blue (d). Caveolin immunoreactivity in endothelial cells lining the ventricles at 3, 7, 14, and 28 days after injury (e),
scale = 100 μm. Mean ± SEM proportion of the ventricle lined with caveolin-1+ cells (f). n = 7–12. *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001, ****p≤ 0.0001
Fig. 11 Fibrinogen immunoreactivity in the brain following partial optic nerve transection. Mean ± SEM fibrinogen immunoreactivity assessing a area and
b intensity above a constant set threshold in control uninjured optic nerve, compared to 1, 3, 7, 14, and 28 days, assessed separately for the right- and
left-hand sides of the brain. Lower, middle, and upper regions of the optic tract were assessed separately. n= 5–6/group. *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001,
****p≤ 0.0001. Representative images of the upper tract (c) show breaches in the BBB indicated by increased areas of diffuse fibrinogen immunoreactivity
(bracketed), 3 days after injury, compared to control uninjured, and 7 and 14 days following partial optic nerve transection. Scale bar for c: 100 μm
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returned to levels that were not significantly different from
uninjured controls (p > 0.05), and these levels were main-
tained at 7 days post-injury (Fig. 12). The pro-inflammatory
cytokine IL-2 was significantly elevated in the rat brains at
an early time point following injury, 1 day (1.4-fold in-
crease, p < 0.05, F = 2.12, df = 3), remained elevated at
3 days post-injury (1.4-fold increase, p < 0.05, F = 2.12, df
= 3), and decreased to levels not significantly different
from controls at 7 days post-injury (Fig. 12). IL-10 is
regarded primarily as an anti-inflammatory cytokine, hav-
ing a potent inhibitory effect on the production of several
pro-inflammatory mediators including TNFα and IL-1β.
IL-10 levels were biphasic, being significantly elevated
from control levels at both an early time point, 1 day
(1.6-fold increase, p < 0.001, F = 13.28, df = 3), and a
later time point, 7 days (1.4-fold increase, p < 0.05, F =
13.28, df = 3) post-injury, with a decline to control levels
in between at 3 days post-injury (Fig. 12).
Discussion
The current study has provided evidence that an injury
to the optic nerve instigates a remote response in the
brain in a time-dependent manner, with production of
both pro- and anti-inflammatory cytokines and increases
in resident and infiltrating inflammatory cells (for sum-
mary of outcomes including relevant published data in
this model, see Fig. 13). Cytokines were rapidly increased
in the brain, prior to changes in the measured inflamma-
tory cell populations in the ventral portion of the optic
nerve, immediately adjacent to the injury. Inflammatory
cell infiltration was evident in well-defined regions of
the brain with significant accumulation being limited to
the contralateral side of the brain. Specific populations
of inflammatory cells were increased in a region-specific
manner. Increases in the density of resident IBA1+ cells
were seen in the lower and middle regions of the contra-
lateral optic tract and the superior colliculus as early as
3 days post-injury. However, increases in the number of
leukocytes and activated microglia and macrophages
relative to control, indicated by CD11b+ and ED1+ cells,
were only evident 7 days post-injury in the upper tract
regions and in the contralateral side of the superior col-
liculus, indicating progression of damage both towards
and from the synaptic terminals. This progression of ac-
tivated inflammatory cells was further confirmed by an
increase in triple-positive CD11b/IBA1/ED1 cells in both
the middle and upper regions of the contralateral optic
tract at 7 days post-injury. Increases in microglia and
macrophages in the ipsilateral optic tract were minimal
and not significant. Importantly, breaches to the BBB
can precede inflammation, particularly apparent in the
upper tract in this study. Taken together, the data indi-
cate that an injury to the optic nerve results in rapid
changes towards the synaptic terminals of affected ret-
inal ganglion cells, which initiate localized inflammatory
cell infiltration perhaps potentiated by early increases in
selected cytokines. Further studies will be required to
determine whether similar changes also occur in an an-
terograde trans-synaptic fashion, for example, in corti-
cally connected regions [44, 45].
Delayed secondary damage often occurs to remote
brain regions that are anatomically connected to the pri-
mary infarct by axonal projections. Studies in rats using
middle cerebral artery occlusion as an ischemia model
consistently show that distinct regions of the thalamus
with axonal connections to the primary infarct develop
gliosis, inflammation, and significant neuronal loss at de-
layed post-stroke time points [29]. In our current study,
a commonality among all observations of altered inflam-
matory cell density and BBB permeability in the brain is
the axonal connectedness of these regions with the
primary injury site, i.e., most significant alterations are
observed in the contralateral optic tract and superior
colliculus, which house the majority of injured axons
that cross over at the optic chiasm, suggesting a role for
axonal degeneration and potential white matter path-
ology, suggested to be of functional relevance for
post-stroke recovery [33]. Our findings indicate that re-
mote damage is limited to areas connected to the pri-
mary injury site. However, it is important to note some
limitations of the current study. Only one section per
brain region was analyzed, and we did not examine all
visual projections, such as the lateral geniculate nucleus.
In addition, the analyses of cytokines used whole brain
homogenates and thus were not confined to axonally
connected pathways. Nevertheless, we observed a
Fig. 12 Multiplex analysis of cytokines in the brain following injury.
Data are expressed as mean ± standard error of mean. *p≤ 0.05,
**p≤ 0.01, ***p≤ 0.001, ****p≤ 0.0001, one-way ANOVA
(Tukey’s correction)
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significant increase in the anti-inflammatory cytokine,
IL-10, at 7 days post-injury, which coincided with in-
creased numbers of microglia in the brain, perhaps indi-
cating a concerted response by anti-inflammatory cell
subtypes at this time. Depletion of CD11b+ cells
worsens damage 24 h following ischemic injury, associ-
ated with increased pro-inflammatory indicators, and
similar mechanisms may act here [46]. Further, more fo-
cused assessments may provide additional insight. It is
also important to note that PVG rats have particular
susceptibilities to immune challenges [47]. Indeed, there
are strain-specific differences for many outcomes in rats
[48]. PVG rats were initially chosen for our studies using
the partial optic nerve transection model of secondary
degeneration, as they are not albino and therefore have
better vision for assessments of visual function following
injury. Female rats were chosen for ease of housing and
to provide much needed and oft-missing information on
injury outcomes in female animals.
Using Evans blue dye, we have observed breaches in
the BBB in the brain as early as 1 day after this partial
optic nerve injury [38], at the same time as both the
current observed increases in both pro- (IL-2, TNFα)
and anti- (IL-10) inflammatory cytokines in whole brain
homogenates. While IL-2 and TNFα can cross the BBB
[49, 50], and IL-10 cannot [51] the breached BBB may
have facilitated entry of cytokines, elevated as a result of
optic nerve injury, into the brain from the circulation.
Fig. 13 Summary of study outcomes. ↑ indicates a significant increase relative to uninjured control, ↑↑ indicates a further increase, and ↓ indicates a
significant decrease (p≤ 0.05) in a measured marker relative to control; “-” indicates no change relative to control. A space indicates not yet tested.
Note that data for the optic tract are referring to the contralateral left-hand side, unless specifically indicated. Small numbers refer to references to
published literature
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The delayed increases in inflammatory cell numbers ob-
served in the middle contralateral optic tract at 7 days
post-injury coincided with a significant increase in the
area of fibrinogen-positive signal in this brain region, in-
dicating associated alterations in BBB permeability.
Increases in microglia- and macrophage-derived cyto-
kines including TNFα correlate with immune cell infil-
tration and have been implicated in the modulation of
endothelial cell function [28] and changes in BBB per-
meability [52]. Reactive oxygen species generated by
macrophages [7] also compromise BBB integrity [50].
Thus, while BBB breaches in the upper tract precede,
and may contribute to increases in inflammatory cells,
multiple factors may be contributing to a feed forward
system exacerbating the damage. While it is clear from
our earlier published work that infiltration of microglia
and macrophages also occurs at the partial optic nerve
injury site and spreads in an efferent direction towards
the brain along the nerve vulnerable to secondary de-
generation [38, 39], it now becomes apparent that as
time passes, inflammation may also move from degener-
ation in the upper tract and synaptic terminals back to-
wards the injury. The anti-inflammatory cytokine IL-10
increases in brain homogenates in a biphasic pattern, be-
ing elevated at 1 day, returning to control levels at 3 days
and elevated at 7 days after injury, likely as a compensa-
tory response, associated with the later changes in
microglia/ macrophage activation and phagocytosis. Fur-
ther studies assessing cytokines in specific brain regions
identified in this study as sites of inflammatory cell infil-
tration, pooling tissue from multiple animals, will be re-
quired to determine the direct relationships between
cytokine changes, cellular infiltrations, and BBB breach.
At later times after injury, there is a disruption to
caveolin-1 immunoreactivity lining the ventricles, indi-
cating that compromise of the BBB is not swiftly re-
solved and that injury to the optic nerve has persisting
remote consequences in the brain.
While the increase in CD45+ cells in the optic nerve
was transient, decreasing to control levels at 28 days
following injury, the number of CD11b+ cells in the
ventral optic nerve remained elevated at 28 days follow-
ing injury. Similarly, iNOS and Arg1 expression were
significantly increased within the ventral optic nerve
7 days after injury compared to uninjured controls,
with only iNOS levels decreasing to control at 28 days
post-injury. Interestingly, cells showed concurrent
expression of iNOS and Arg1 indicating that these im-
munoreactive cells exhibit a mixed phenotype, as previ-
ously shown following traumatic brain injury [18].
Similar findings have also been reported in the cortex
following spared nerve injury to the sciatic nerve [26].
As both microglia and infiltrating non-myeloid-derived
leukocytes express CD11b and CD45 markers, but differ
in the levels of expression of these markers, i.e., infiltrating
leukocytes have high CD45 expression compared to resi-
dent microglia, we were unable to differentiate microglia
from macrophages and leukocytes in general in this in-
stance. Interestingly, CD45+ cells were not elevated in the
optic tract, indicating differences in the features of the ad-
jacent and remote inflammatory responses.
Conclusion
In summary, our study demonstrates that a partial injury
to the optic nerve induces transient changes in whole
brain cytokine expression and increased inflammatory
cell density and BBB permeability remotely along the
visual pathways in the brain. Significant alterations are
restricted to the contralateral side of the brain, suggest-
ing that, at least in this traumatic injury model, inflam-
matory and BBB damage is confined to regions that are
“axonally connected” to the primary injury site, although
it remains to be determined whether such damage also
extends trans-synaptically.
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